TY - GEN AU - Levy,J H AU - Pifarre,R AU - Schaff,H V AU - Horrow,J C AU - Albus,R AU - Spiess,B AU - Rosengart,T K AU - Murray,J AU - Clark,R E AU - Smith,P TI - A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting SN - 0009-7322 PY - 1995///1114 KW - Aged KW - Aprotinin KW - administration & dosage KW - Blood Loss, Surgical KW - prevention & control KW - Blood Transfusion KW - Blood Volume KW - Coronary Artery Bypass KW - Dose-Response Relationship, Drug KW - Double-Blind Method KW - Female KW - Hemostatics KW - Humans KW - Incidence KW - Male KW - Middle Aged KW - Myocardial Infarction KW - epidemiology KW - Postoperative Complications KW - Prospective Studies KW - Renal Insufficiency KW - Reoperation KW - Risk Factors KW - Serine Proteinase Inhibitors N1 - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't UR - https://doi.org/10.1161/01.cir.92.8.2236 ER -